secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2026-03-17T23:59:59+00:00
Accession:  0001493152-26-010594
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience closes $215K Regulation A offering of Series A Preferred Stock and warrants
--------------------------------------------------------------------------------

- Issued 43,050 Investor Units at $5.00/unit; each unit contains one share of Series A Convertible Preferred and two common stock purchase warrants.
- Total gross proceeds of approximately $215,250; warrants exercisable for up to 86,100 shares of common stock.
- Offering qualified by SEC on January 5, 2026 under Regulation A; terms previously reported in Form 8-K filed January 29, 2026.
- Proceeds provide additional working capital for the company's development programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315226010594/0001493152-26-010594-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315226010594/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-010594

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer